Member Info for ChrisToffer

That's good for me, your link still doesn't work cause it's a load of ******

That's brilliant Pro! That and the Clinton connection on the HIV test!

Piper you wanna find some proper evidence to back up what you're saying before calling people 'tards.

I completely agree with you Ferrari and hold the same position on it all! Apologies that got directed at you!

That link doesn't work ********.

Yea alright i'll take that! i guess i'm just sick seeing the same post, there is also a lot of nonsense being spouted here this morning (about the government order) and my main gripe was with that.

I should add that what you're posting is true Ferrari however none of it is new so only serves to ramp the share.

Ferrari that's the same post you put up several times a day. Has anyone got a link to the Government order of antibody tests because all that seems to be out there is the hint from them that they're gonna miss the target of 100,00 tests a day.

Does everyone here realise that bull**** in any form actually misinforms a good investment decision?

Can someone post a link of the report for this antibody order?

Henners, how quickly they can recruit home patients is a little subjective. If they concentrated on care homes they might fill the number quite quickly.
What makes you think this puts SNG behind their competitors? What competitors are at this stage of a phase 2 trial? Are they double blind placebo trials (which helps to achieve a faster approval)? And what competitors have a drug that can be self administered in the home at the first sign of symptoms and confirmation of the virus?

They haven't confirmed that it works. What it almost assuredly means is that it is safe because patients who have been released from hospital during the 14 day trial have been using it at home and they are now going to start trials at home.

Richard Marsden said in the interview (think it was the one with Finncap) that SNG are in a good position in that they had a placebo standing by to support these trials. A lot of other drugs being trialed, namely Remdesivir, are not double blind placebo trials putting them at a significant disadvantage of getting the correct level of approval (and confidence) for this disease.

Punit, https://www.hra.nhs.uk/covid-19-research/approved-covid-19-research/281317/

Trials have been expanded to start in homes, see the amendments to the trial register in that link.

Me too Mike. Although the amendments are just amendments, the expansion of the trial to homes is fairly significant news and you would think would directly affect SP. Hopefully they're putting together a more comprehensive update to release at once!

I give up! its you funeral mate haha

What your suggesting Jack is that they do it in a half arsed manner whereby they get half an approval that can only be administered by professionals and they'd have to come back to this stage to get it approved for home use. They will want to get this approved once and for all and the only way to do that is to gather as much evidence as possible.

Jack. The approval does not occur half way through the trial. They spend the trial gathering as much data as they can to support their approval application and then submit it for what is usually an independent review. The more stages of infection that they can try the drug on the better data they will have to support the trial application.

@Warrenbe, the trial has been expanded to home patients https://www.hra.nhs.uk/covid-19-research/approved-covid-19-research/281317/

Jack, the piece that you are referring to it this,

'testing for confirmation of COVID-19 is currently being done at hospital laboratories and results are taking 24-36 hours to come through. We are finding that patients often have had COVID-19 symptoms for an average of 7-10 days by the time they are admitted to hospital. Ideally we would like patients to receive the first dose of study medication as early as possible into their illness to give it it’s best chance of working and to stop the further spread of the virus, therefore waiting for a further 24-36 hours after the patient is admitted to find out the hospital laboratory results is not ideal.'

That is the first amendment to the document that allowed point of care testing so they didn't have to wait 24-26 hours for confirmation of the infection before starting the trial.

That is not the justification for expanding the scope of the trial , which is the latest amendment.

You're paraphrasing Jack! The ideal time to apply the drug is earlier in the treatment. Due to the nature of testing available and because the trial had to start in a hospital (to firstly confirm safety of the drug) they have not been able to target patients in the drugs ideal stage to help treat the virus. That doesn't necessarily mean the data they've gathered so far is no good because, Step-by-step it has allowed them to start trialing in homes where they confidently believe the drug is best put to use.